deltatrials
Completed PHASE2 NCT00004689

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

Sponsor: National Jewish Health

Conditions Mycobacterium Avium-intracellulare Infection
Interventions amithiozone clarithromycin ethambutol rifampin streptomycin
Updated 5 times since 2017 Last updated: Mar 24, 2015 Started: Jan 31, 1991 Completion: Sep 30, 1998

This PHASE2 trial investigates Mycobacterium Avium-intracellulare Infection and is currently completed. National Jewish Health leads this study, which shows 5 recorded versions since 1991 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jan 1991

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Jewish Health
Data source: FDA Office of Orphan Products Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.